Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Oxford Science Enterprises
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Trellis BioscienceSeries C $9M · 3 mo ago
Trellis Bioscience is developing native human antibodies to disrupt bacterial biofilms and address difficult-to-treat infections.
Alentis TherapeuticsSeries D $181.4M · 23 mo ago • Founded 2019 • 51-200 employees
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…
RQ Biotechnology11-50 employees
RQ Bio develops long-acting monoclonal antibodies for seasonal influenza, offering immediate, potent, and lasting protection against severe…
Biolinco201-500 employees
High-throughput cell line development for biopharmaceuticals. DNA barcoding platform that screens thousands of CHO cell lines…
Granite Bio AG51-200 employees • 5 roles
Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting…
Alloy TherapeuticsSeries E $40M · 6 mo ago • Founded 2020 • 51-200 employees • 9 roles
Alloy Therapeutics democratizes access to antibody discovery and biologics discovery technology to enable and advance drug discovery in…

Overview

Barinthus Biotherapeutic induces T cells and antibodies to treat and prevent disease.